Several chemotherapeutics, including TMZ, are being used to treat SCLC [27], making the H69 cell line a suitable model for pre-clinical in vivo PRRT research using radiolabelled SST analogues [28]. This evidence concerns the gene SST and small cell lung carcinoma.